Business UpdateJun 22, 2026, 05:41 PM
Telix Pharmaceuticals to Host Webinar on Neurologic Oncology
AI Summary
Telix Pharmaceuticals Limited announced an upcoming educational webinar focused on neurologic oncology, specifically glioma and glioblastoma, and the potential role of theranostics. The event will feature a clinical update from Telix's Group Chief Medical Officer, David N. Cade, MD, followed by a fireside chat with leading experts Dr. Nelleke Tolboom and Dr. Josef Pichler. The webinar is scheduled for June 29, 2026, at 5:00 p.m. EDT, aiming to address unmet medical needs in this area.
Key Highlights
- Telix Pharmaceuticals to host an educational webinar on neurologic oncology and theranostics.
- Webinar will explore unmet needs in glioma and glioblastoma.
- Features Telix Group Chief Medical Officer, David N. Cade, MD, providing a clinical update.
- Includes a fireside chat with Dr. Nelleke Tolboom (UMC Utrecht) and Dr. Josef Pichler (Kepler University Hospital Linz).
- Webinar scheduled for June 29, 2026, at 5:00 p.m. EDT.
Price Impact
More from TLX